|
DRAXXIN
|
100 mg/ml
|
EU/2/03/041/003
|
Zoetis Belgium S.A., Beļģija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
FAREVA AMBOISE, Francija;Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
19-Aug-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/041/003 |
100 mg/ml |
1 |
Stikla pudelīte, 100 ml |
[PDF]
|
|
|
Porcilis PCV M Hyo
|
-
|
EU/2/14/175/004
|
Intervet International B.V., Nīderlande
|
QI09AL
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae,Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
30-Nov-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/175/004 |
|
1 |
PET pudele, 100 deva |
-
|
|
|
Melovem
|
15 mg/ml
|
EU/2/09/098/008
|
Dopharma Research B.V., Nīderlande
|
QM01AC06
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dopharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
06-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/098/008 |
|
1 |
ABPE pudele, 100 ml |
-
|
|
|
Daxocox
|
100 mg
|
EU/2/21/270/029
|
Ecuphar NV, Beļģija
|
QM01AH95
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Enflicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
20-Apr-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/270/029 |
100 mg |
1 |
Blisteris, 4 tablete |
-
|
|
|
Nobivac DHPPi
|
-
|
V/I/26/0017
|
Intervet Ireland Ltd, Īrija
|
QI07AD04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live Canine parainfluenza virus (CPi) strain Cornell,Live Canine adenovirus type 2 (CAV2), strain Manhattan LPV3,Live Canine distemper virus (CDV) strain Onderstepoort,Live Canine parvovirus (CPV), strain 154
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
08-Apr-2026
|
| Marketing authorisation valid until: |
07-Apr-2031
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 08042026LI (08-Apr-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/26/0017-01 |
|
10 |
Stikla flakons; satur liofilizētu granulu, 1 deva |
[PDF]
|
|
|
Porcilis PCV ID
|
-
|
EU/2/15/187/001
|
Intervet International B.V., Nīderlande
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
27-Aug-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/187/001 |
|
1 |
Stikla flakons, 10 ml |
-
|
|
|
ArthriCox
|
57 mg
|
EU/2/24/323/002
|
Chanelle Pharmaceuticals Manufacturing Limited, Īrija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Oct-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/323/002 |
|
60 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Advocate Spot-on šķīdums lieliem suņiem
|
-
|
EU/2/03/039/010
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
14-Jan-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/010 |
|
6 |
Pipete, 2,5 ml |
-
|
|
|
Rabigen SAG2
|
-
|
EU/2/00/021/002
|
Virbac S.A., Francija
|
QI07BD
|
foxes
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Attenuated live rabies virus
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
16-Mar-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/00/021/002 |
|
400 |
Trauciņš, 400 deva |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/013
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 20-40 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/013 |
|
1 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Nobivac L4
|
-
|
EU/2/12/143/004
|
Intervet International B.V, Nīderlande
|
QI07AB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000),L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001),L. interrogans serogroup Australis serovar Bratislava (strain As-05-073),L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
15-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/143/004 |
1 deva |
50 |
Flakons, 1 deva |
-
|
|
|
BRAVECTO TriUNO
|
-
|
EU/2/24/325/002
|
Intervet International B.V., Nīderlande
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Fluralaner, Moxidectin, Pyrantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
22-Nov-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/325/002 |
|
3 |
Blisteris, 1 tablete |
-
|
|
|
EVANT
|
-
|
EU/2/18/233/002
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for oral spray
|
| International name (active substance): |
Eimeria acervulina, strain 003, Eimeria maxima, strain 013, Eimeria mitis, strain 006, Eimeria praecox, strain 007, Eimeria tenella, strain 004
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
05-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| -01 |
|
1 |
Stikla flakons un flakons, 5000 deva |
-
|
|
|
Prac-tic
|
137.5 mg
|
EU/2/06/066/005
|
Elanco GmbH, Vācija
|
QP53AX26
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Pyriprole
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
16-Nov-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/066/005 |
137,5 mg/deva |
6 |
Pipete, 1 deva |
-
|
|
|
Aivlosin
|
625 mg/g
|
EU/2/04/044/014
|
ECO Animal Health Europe Limited, Īrija
|
QJ01FA92
|
pheasants
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
granules for use in drinking water
|
| International name (active substance): |
Tylvalosin (as Tylvalosin tartrate)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Cod Beck Blenders Limited, Lielbritānija
|
| Date of authorisation/renewal: |
09-Sep-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/044/014 |
|
1 |
Folijas paciņa, 400 g |
-
|
|
|
FRONTPRO
|
11.3 mg
|
EU/2/19/240/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs 2–4 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/003 |
11,3 mg |
1 |
PVH/Aclar/Al blisteris, 6 tablete |
-
|
|
|
Solensia
|
7 mg/ml
|
EU/2/20/269/001
|
Zoetis Belgium S.A., Beļģija
|
QN02BG90
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Frunevetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
17-Feb-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/269/001 |
7 mg/ml |
1 |
Stikla flakons, 1 ml |
-
|
|
|
BioBos BTV 3
|
-
|
V/I/26/0003
|
Bioveta a.s., Čehija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus, serotype 3, strain Bio-93:BTV3, inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
26-Jan-2026
|
| Marketing authorisation valid until: |
25-Jan-2031
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 26012026LI (26-Jan-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/26/0003-01 |
|
1 |
ABPE flakons (kartona kastē), 50 devas/flakonā |
[PDF]
|
|
|
Bluevac BTV8
|
-
|
EU/2/11/122/003
|
C.Z. Veterinaria, Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus serotype 8 antigen
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
C.Z. Veterinaria, Spānija
|
| Date of authorisation/renewal: |
13-Apr-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/122/003 |
|
1 |
Flakons, 126 deva |
-
|
|
|
Oxyglobin
|
130 mg/ml
|
EU/2/99/015/001
|
Biopure Netherlands B.V., Nīderlande
|
QB05AA90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for infusion
|
| International name (active substance): |
Haemoglobin glutamer-200 (bovine)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dales Pharmaceuticals Ltd., Lielbritānija
|
| Date of authorisation/renewal: |
01-Oct-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/015/001 |
130 mg/ml |
2 |
Maisiņš, 125 ml |
-
|
|